• Publications
  • Influence
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast‐enhanced MRI protocols
To retrospectively determine the incidence of nephrogenic systemic fibrosis (NSF) in patients on dialysis administered either a lower dose high‐relaxivity linear gadolinium‐chelate, gadobenateExpand
  • 86
  • 7
Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.
OBJECTIVE Attenuation values on CT of less than 10 H are considered characteristic of adrenal adenomas. Adrenal pheochromocytomas can infrequently contain fat that could result in low attenuation onExpand
  • 138
  • 5
On improving temporal and spatial resolution of 3D contrast-enhanced body MR angiography with parallel imaging.
Use of a parallel imaging technique to improve temporal and spatial resolution at three-dimensional contrast-enhanced magnetic resonance (MR) angiography was investigated. Thirty experiments wereExpand
  • 40
  • 1
Management of regorafenib-related toxicities: a review
Regorafenib (Stivarga, BAY 73-4506; Bayer Pharma AG, Berlin, Germany) is an oral multikinase inhibitor that targets the angiogenic tumor microenvironment and oncogenic kinases including vascularExpand
  • 33
  • 1
Value of non-contrast sequences in magnetic resonance angiography of hepatic arterial vasculature.
OBJECTIVE To evaluate value of adding non-contrast MR angiographic sequence (In-Flow Inversion Recovery [IFIR]) to standard fat-suppressed T1-weighted postcontrast sequence (3D spoiled gradient echoExpand
  • 3
Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy
BackgroundIntraperitoneal chemotherapy is used to treat peritoneal surface-spreading malignancies. We sought to determine whether volume and surface area of the intraperitoneal chemotherapyExpand
  • 8
Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients
Objectives:Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. CA19-9 is a glycoprotein that predicts poor prognosis in pancreatic and biliary malignancies.Expand
  • 9
PET scanning: worth the cost in cancer? Not for all cancers--it's not reliable enough yet.
In order for a test to be reliable, it must be reproducible and minimize test-retest variability. Yet, as with many imaging tests, FDG-PET has variance in standard uptake value (SUV) calculations,Expand
  • 4
On Improving Temporal and Spatial Resolution in 3D Contrast-enhanced Body MRA with Parallel Imaging
Q. Chen, C. V. Quijano, V. M. Mai, S. K. Krishnamoorthy, W. Li, P. Storey, R. R. Edelman Evanston Northwestern Healthcare, Evanston, IL, United States, Northwestern University Feinberg School ofExpand
  • 2
Highlights on novel imaging methods of pancreatic cancer.
Pancreatic cancer is the fourth leading cause of cancer deaths. Since the majority of patients present with incurable metastatic disease, novel imaging methods are needed to identify pancreaticExpand
  • 1